|
|
Office Locations:
|
57 West 57th Street, Suite 904
New York, NY 10019
Phone: 212-901-8000
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
The Alzheimer's Drug Discovery Foundation (ADDF) has been leading the way in Alzheimer's research since its founding in 1998. Thanks to the generosity of founders, Leonard A. Lauder and Ronald S. Lauder, 100% of every dollar donated to goes directly to science. The ADDF has awarded nearly $250 million to fund over 720 Alzheimer's drug discovery programs, biomarker programs and clinical trials in 19 countries. ADDF makes investments, not grants, in research. Employing a venture philanthropy model, the ADDF is helping to shape the Alzheimer's research pipeline through both scientific leadership and providing venture capital for innovative, often underfunded research areas.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
